![](/img/cover-not-exists.png)
A Phase I/II Study of LY900003, an Antisense Inhibitor of Protein Kinase C- , in Combination with Cisplatin and Gemcitabine in Patients with Advanced Non-Small Cell Lung Cancer
Villalona-Calero, M. A.Volume:
10
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-04-0779
Date:
September, 2004
File:
PDF, 110 KB
english, 2004